Literature DB >> 28115456

Higher medication doses in heart failure?

James McCormack1, Finlay A McAlister2, Michael R Kolber3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28115456      PMCID： PMC5257235     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  13 in total

1.  Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.

Authors:  Finlay A McAlister; Natasha Wiebe; Justin A Ezekowitz; Alexander A Leung; Paul W Armstrong
Journal:  Ann Intern Med       Date:  2009-06-02       Impact factor: 25.391

2.  Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure.

Authors:  Luigi Tavazzi; Aldo P Maggioni; Jeffrey S Borer
Journal:  Eur Heart J       Date:  2013-07-25       Impact factor: 29.983

3.  Aldosterone antagonists in systolic heart failure.

Authors:  Adrienne J Lindblad; G Michael Allan
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

4.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur J Heart Fail       Date:  2016-05-20       Impact factor: 15.534

5.  Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

Authors:  M Packer; P A Poole-Wilson; P W Armstrong; J G Cleland; J D Horowitz; B M Massie; L Rydén; K Thygesen; B F Uretsky
Journal:  Circulation       Date:  1999-12-07       Impact factor: 29.690

6.  Minimal dose for effective clinical outcome and predictive factors for responsiveness to carvedilol: Japanese chronic heart failure (J-CHF) study.

Authors:  Hiroshi Okamoto; Masatsugu Hori; Masunori Matsuzaki; Hiroyuki Tsutsui; Tsutomu Yamazaki; Ryozo Nagai; Tsutomu Yoshikawa; Yasushi Fujio; Shinpei Nonen; Junichi Azuma; Tohru Izumi; Yasuo Ohashi; Akira Kitabatake
Journal:  Int J Cardiol       Date:  2012-12-12       Impact factor: 4.164

7.  Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.

Authors:  Marvin A Konstam; James D Neaton; Kenneth Dickstein; Helmut Drexler; Michel Komajda; Felipe A Martinez; Gunter A J Riegger; William Malbecq; Ronald D Smith; Soneil Guptha; Philip A Poole-Wilson
Journal:  Lancet       Date:  2009-11-16       Impact factor: 79.321

Review 8.  The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure.

Authors:  Robert S McKelvie; Gordon W Moe; Justin A Ezekowitz; George A Heckman; Jeannine Costigan; Anique Ducharme; Estrellita Estrella-Holder; Nadia Giannetti; Adam Grzeslo; Karen Harkness; Jonathan G Howlett; Simon Kouz; Kori Leblanc; Elizabeth Mann; Anil Nigam; Eileen O'Meara; Miroslaw Rajda; Brian Steinhart; Elizabeth Swiggum; Vy Van Le; Shelley Zieroth; J Malcolm O Arnold; Tom Ashton; Michel D'Astous; Paul Dorian; Haissam Haddad; Debra L Isaac; Marie-Hélène Leblanc; Peter Liu; Vivek Rao; Heather J Ross; Bruce Sussex
Journal:  Can J Cardiol       Date:  2012-11-30       Impact factor: 5.223

9.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

10.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Authors:  Marc A Pfeffer; John J V McMurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Køber; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf
Journal:  N Engl J Med       Date:  2003-11-10       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.